Meitu’s Stock Price Soars to 4.20 HKD, Witnessing a Stellar Gain of +15.38%

Meitu (1357)

4.20 HKD +0.56 (+15.38%) Volume: 90.56M

Meitu’s stock price has experienced a significant surge, currently trading at 4.20 HKD, marking an impressive session increase of +15.38%. The trading volume stands at 90.56M, demonstrating heightened investor interest. With a remarkable +41.41% rise YTD, Meitu (1357) continues to show robust performance in the stock market.

Latest developments on Meitu

Today, Meitu Inc‘s stock price saw significant movements as various key events unfolded. The Hang Seng Index (HSI) closed midday at 20,225, up 27 points, while the Hang Seng Tech Index (HSTI) closed at 4,723, up 36 points. Additionally, Ali Health surged over 4% in trading. Notably, companies like Xiaomi, Meitu, and Kingsoft hit new highs, contributing to the overall market sentiment and impacting Meitu Inc‘s stock price.

A look at Meitu Smart Scores

Smart Score is a compound score for the Company indicating its overall outlook. It is derived by taking an equally weighted average of underlying Factor scores computed by Smartkarma

Meitu Inc, a company that specializes in mobile application software, has received positive ratings across various factors according to Smartkarma Smart Scores. With a high score in Growth and Dividend, the company seems to have a promising long-term outlook. This indicates that Meitu Inc is well-positioned for future expansion and profitability, making it an attractive option for investors looking for growth potential.

Despite scoring slightly lower in Value and Resilience, Meitu Inc still maintains a strong overall outlook with solid scores in Momentum. This suggests that the company is actively progressing and gaining momentum in the market. With its focus on image editing, live broadcasting, and social software, Meitu Inc‘s diverse portfolio and global presence in mobile designing and retailing further contribute to its positive long-term prospects.

Disclaimer: This article by Smartkarma is general in nature and based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Note that our articles may not factor in the latest price-sensitive company announcements or qualitative material.
While all reasonable care has been taken in the preparation, Smartkarma makes no assurance about the accuracy of any generated data or content. All content is indicative only and should be independently checked for accuracy and confirmed before use. Smartkarma accepts no responsibility for any loss or damage caused as a result of any inaccuracy or error within the Lab online tools or generated data.
Have feedback on this article? Concerned about the content? Get in touch with us directly.

💡 Before it’s here, it’s on Smartkarma